Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-24, Stock:NVO, The news for the past five days is as follows:
2021-11-17: NEWS1: The Zacks Analyst Blog Highlights: Adobe, Novo Nordisk, Qualcomm, Boeing, and Uber.NEWS2: GSK or NVO: Which Is the Better Value Stock Right Now?.NEWS3: 3 Big Pharma Outperformers to Watch Out For in the Near Term.
2021-11-18: NEWS1: Dicerna Stock Rockets On Novo Nordisk's $3.3 Billion Takeover Plan.NEWS2: DICERNA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of DRNA and Encourages Investors to Contact the Firm.NEWS3: RNAi firm Dicerna Pharmaceuticals to be acquired for $3.3B.NEWS4: Why Dicerna Pharmaceuticals Stock Is Rocketing Higher Today.NEWS5: DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing Today.NEWS6: Dicerna Stock Skyrockets as Novo Nordisk to Buy Research Partner for $3.3 Billion.NEWS7: Novo Nordisk Swallows Dicerna In $3.3B Buyout: All You Need To Know.NEWS8: The Zacks Analyst Blog Highlights: Eli Lilly, Pfizer and Novo Nordisk.NEWS9: UPDATE 3-Denmark's Novo Nordisk to buy Dicerna Pharma for $3.3 billion.NEWS10: Novo Nordisk strikes $3.3 billion deal to buy research partner Dicerna Pharmaceuticals.NEWS11: Denmark's Novo Nordisk to buy Dicerna Pharma for $3.3 billion.NEWS12: Novo Nordisk to Acquire Dicerna Pharmaceuticals in $3.3B Deal.NEWS13: Novo Nordisk Agrees to Buy Dicerna Pharma for $3.3 Billion.
2021-11-19: NEWS1: Novo Nordisk (NVO) Set to Acquire Dicerna for $3.3 Billion.
2021-11-22: NEWS1: Novo Nordisk A/S – Share repurchase programme.
2021-11-23: NEWS1: 4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout.

Answer: Decrease